Anxiety News and Research

Latest Anxiety News and Research

Pfizer's new pipeline shows growth and diversity in research and development

Pfizer Inc. today provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy companies, includes 133 programs from phase 1 through registration, and shows growth and increased diversity in each of the areas where the company invests in research and development.

28 Jan 2010

NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform

The effort to fix our dysfunctional, inequitable and unsustainable health system is at a crucial juncture. Without prompt and decisive leadership, defeat, as it has for over a century, will again prevail over reform.

28 Jan 2010

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Church & Dwight Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared the FIRST RESPONSE® Early Result Pregnancy Test which can determine pregnancy up to six days before the day of a woman's missed period

27 Jan 2010

Discovery could help improve diagnosis and treatment for anxiety disorders

Draw a map of the brain when fear and anxiety are involved, and the amygdala-the brain's almond-shaped center for panic and fight-or-flight responses-looms large.

27 Jan 2010

Research suggests people are more likely to stick with weight control program with group support

Most of life's circumstances are beyond our control. Family, work and busy schedules can bring all of us a certain amount of stress and anxiety. In my work with patients with difficulty managing their weight, stress is often reported as the number one thing that triggers emotional eating, which means reaching for food for comfort and support rather than asking for help. Why? Because asking for help is hard.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

Testing DBS for treating severe long-term depression

Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.

27 Jan 2010

UK Gill Heart Institute offers individualized fitness program for heart patients

How do you change health habits among a population with some of the highest heart disease rates in the world? Tackling heart disease in Kentucky - an epicenter of heart health problems - the University of Kentucky Gill Heart Institute Cardiac Rehabilitation Program is helping high-risk patients make radical, lasting changes to improve their heart health.

23 Jan 2010

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

The U.S. Food and Drug Administration has approved the marketing of Ampyra™ (dalfampridine, formerly known as fampridine SR, from Acorda Therapeutics) for its ability to improve walking speed in people with any type of multiple sclerosis.

23 Jan 2010

Heart murmurs in pediatric patients is not a serious condition, says physician

Your 3-year-old's doctor discovers a heart murmur during a visit for a mild cold with fever and recommends referral to a pediatric cardiologist. You worry and wonder how your healthy, active child could possibly have a heart problem.

23 Jan 2010

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia.

22 Jan 2010

Tips to identify signs of eating disorders

It's estimated that one-third of Americans made a New Year's resolution to lose weight this year. Though these dieting individuals may have healthy intentions, they could be putting themselves at risk for an eating disorder, warns Eating Recovery Center (www.eatingrecoverycenter.com), a licensed and Joint Commission accredited behavioral hospital providing comprehensive treatment and sustainable recovery for eating disorders.

22 Jan 2010

Today's selection of opinions and editorials

For now it appears that Washington's polarizing ways, and public anxiety about change, have again left Americans with the most expensive, least reliable health care system in the developed world. No matter who you are, that's hardly cause to celebrate (1/21).

21 Jan 2010

Training health personnel in emotional intelligence can help women from developing depressive symptoms

The extent of mental health problems is increasing, and has become one of the biggest challenges facing Europe today. As much as 10-25 per cent of women are at risk of developing serious depression during their lifetime.

21 Jan 2010

Local physicians are currently recruiting PTSD patients for clinical research study

Researchers are currently recruiting patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. People who are having symptoms after experiencing a traumatic event or who have been diagnosed with PTSD may be eligible to participate in this study of a new investigational drug.

21 Jan 2010

New study may help develop assessment tests in social-emotional learning

Neurobehavioral researchers at Rush University Medical Center have found three key factors in a child's behavior that can lead to social rejection. The studies are a crucial step in developing scientifically sound screening tests and treatment planning for social-emotional learning difficulties.

20 Jan 2010

DNA testing can help individuals make more-informed health and lifestyle decisions

Mention the term “genetic testing” and reactions can vary widely—from curiosity, to reticence or anxiety, to enthusiastic acceptance. The reality is, DNA testing has been used for decades, primarily to determine the paternity of children and to obtain forensic evidence for police investigations and legal trials.

20 Jan 2010

Extended U.S. Army deployments increase depression, anxiety and sleep disorders for soldiers' wives

The deployment of soldiers to the ongoing conflicts in Iraq and Afghanistan is increasing the need for mental health services provided for their family members, according to a new study by researchers at RTI International, the University of North Carolina at Chapel Hill and the Uniformed Services University of the Health Sciences.

20 Jan 2010

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

An online treatment system for patients suffering with panic disorder and anxiety problems combine biofeedback therapy with web technologies and allows patients and medical professionals to communicate effectively, according to research published in the International Journal of Business Intelligence and Data Mining.

20 Jan 2010

New method for diagnosing post-traumatic stress disorder

Researchers at the University of Minnesota and Minneapolis VA Medical Center have identified a biological marker in the brains of those exhibiting post-traumatic stress disorder (PTSD).

20 Jan 2010

Anxiety News and Research

Latest Anxiety News and Research

Pfizer's new pipeline shows growth and diversity in research and development

NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Discovery could help improve diagnosis and treatment for anxiety disorders

Research suggests people are more likely to stick with weight control program with group support

Scott & White conducts DBS research for Parkinson's patients

Testing DBS for treating severe long-term depression

UK Gill Heart Institute offers individualized fitness program for heart patients

FDA's Ampyra approval wonderful news for people with MS experiencing walking problems

Heart murmurs in pediatric patients is not a serious condition, says physician

Update on the status of Somaxon Pharmaceuticals' NDA for Silenor provided

Tips to identify signs of eating disorders

Today's selection of opinions and editorials

Training health personnel in emotional intelligence can help women from developing depressive symptoms

Local physicians are currently recruiting PTSD patients for clinical research study

New study may help develop assessment tests in social-emotional learning

DNA testing can help individuals make more-informed health and lifestyle decisions

Extended U.S. Army deployments increase depression, anxiety and sleep disorders for soldiers' wives

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

New method for diagnosing post-traumatic stress disorder

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Anxiety News and Research

Latest Anxiety News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in